Not for the first time, J-Star planted the seeds of its latest investment while in pursuit of another deal.
Buyouts | 19 Nov 2014 |
Fubon Life, the second-largest insurer in Taiwan, has committed $30 million to Athyrium Capital Management’s healthcare-focused credit fund.
Greater China | 18 Nov 2014 |
Baring Private Equity Asia has agreed to buy Japan-based Bushu Pharmaceuticals from Tokio Marine Capital at an enterprise valuation of JPY77.3 billion ($670 million).
Exits | 17 Nov 2014 |
Hillhouse Capital and CITIC Private Equity have participated in a RMB450 million ($75 million) round of funding for BeiGene, a Chinese company that develops drugs to combat cancer.
Greater China | 17 Nov 2014 |
Japanese mid-market buyout firm J-Star has acquired two new care providers - Nagoya-headquartered Nurse Call and Kanagawa-based Kairos & Company - within weeks of its 5x exit from similar business HCM Corporation.
North Asia | 13 Nov 2014 |
SoftBank China Venture Capital (SBCVC) and SIG Asia have invested $30 million in a Series B round of funding for Codoon, a Chinese wearable electronic devices manufacturer.
Venture | 07 Nov 2014 |
Chinese drug maker Shenzhen Hepalink Pharmaceutical, previously a highly successful PE investment for Goldman Sachs, has committed $22 million to TPG Capital’s latest biotech fund.
Fundraising | 04 Nov 2014 |
China-focused GP Hony Capital is seeing more buyout opportunities involving healthcare and restaurant chains and it has created two sector-focused operational teams to consolidate these industries.
Greater China | 31 Oct 2014 |
Warburg Pincus has paid INR5.5 billion ($89.6 million) for a minority stake in Indian drug maker Laurus Labs, triggering a partial exit for Fidelity Growth Partners India.
South Asia | 30 Oct 2014 |
Jaguar Animal Health, a veterinary drugs developer backed by China-focused healthcare investor BVCF, is looking to raise as much as $54 million through a NASDAQ IPO.
Exits | 29 Oct 2014 |
Luye Pharma Group, a PE-backed Chinese drug maker, has taken full ownership of its industry peer Beijing Jialin Pharmaceutical, acquiring a 42.02% interest from existing PE shareholders.
Greater China | 27 Oct 2014 |
Fidelity Growth Partners Asia has invested RMB90 million ($15 million) in Zhejiang Banger Medical Management, a Chinese orthopedic hospital operator.
Greater China | 22 Oct 2014 |
Fidelity Growth Partners and existing backer Somerset Indus CapitalFund have invested INR600 million ($9.7 million) in Cygnus Medicare, an Indian operator of specialty hospitals in Delhi and Haryana.
South Asia | 20 Oct 2014 |
BBI Life Sciences Corporation, a Chinese genetic engineering specialist backed by Qiming Venture Partners, has filed for an IPO in Hong Kong. The company has yet to disclose the size and pricing of the offering.
Exits | 17 Oct 2014 |
MID Labs, a US-based medical devices manufacturer that focuses on eye surgery, has received $51 million in funding from a group of investors to support its expansion into China.
Healthcare | 17 Oct 2014 |
Updating your subscription status
As investor's confidence in the domestic economy is restored, Taiwan's private equity sector players are anticipating a long-awaited upswing in activity, especially with a more transparent and open regulatory environment to revive growth. Positive signals from the government include the new M&A regulation, which will add on protection of minority shareholders upon its launch. The National Development Fund has also injected billions of cash into local funds in an effort to support industrial innovation.
20 November 2014, The Westin Hotel, Taipei
With the empathic and historic victory of Narendra Modi at the recent elections in India, the market confidence has improved significantly. Until recently, India was mentioned in financial markets only in a negative light given the enormous potential and lack of delivery. Difficulties in exiting, arbitrary taxation and poor governance are just some of the chronic problems deterring investors.
Discover what repercussions the latest political developments will have on the private equity industry, the outlook for the next wave of fundraising, where GPs expect to source exits and the best way forward for existing and potential investors.
2-3 December 2014, Taj Lands End Hotel, Mumbai